Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 2, 2008, Pages 109-116

  Franzese, Adriana ^a   Valerio, Giuliana ^b   Buono, Pietro ^a   Spagnuolo, Maria Immacolata ^a   Sepe, Angela ^a   Mozzillo, Enza ^a   De Simone, Ilaria ^a   Raia, Valeria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Continuous glucose monitoring system; Cystic fibrosis; Cystic fibrosis related diabetes; Glycosylated hemoglobin; Oral glucose tolerance test

Indexed keywords

ENZYME; GLUCOSE; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING SYSTEM; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ENZYME THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERMETHOD COMPARISON; MALE; ORAL GLUCOSE TOLERANCE TEST; RESPIRATORY TRACT INFECTION; SCREENING TEST;

EID: 41449108884     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2008.21.2.109     Document Type: Article

References (21)

1. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Stradvik B. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from European Epidemiologic Registry of Cystic Fibrosis. Paediatr Pulmonol 2001; 32: 343-350.
2. Rosenecker J, Eichler I, Kuhn L, Harms HK, von der Hardt H. Genetic determination of diabetes mellitus in patients with cystic fibrosis. Multicenter Cystic Fibrosis Study Group. J Pediatr 1995; 127: 441-443.
3. Lombardi F, Raia V, Spagnuolo MI, Nugnes R, Valerio G, Ciccarelli G, Franzese A. Diabetes in an infant with cystic fibrosis. Pediatr Diabetes 2004; 5: 171-173.
4. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polank M. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867.
5. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, Pencharz P, Durie P, Sweezey NB. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003; 142: 128-132.
6. Moran A, Milla C. Abnormal glucose tolerance in cystic fibrosis: why should patients be screened? J Pediatr 2003; 142: 97-99.
7. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994; 83: 849-853.
8. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Zipf WB. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus report. Diabet Res Clin Pract 1999; 45: 61-73.
9. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and β-cell dysfunction. Diabet Med 2002; 19: 221-226.
10. Franzese A, Spagnuolo MI, Sepe A, Valerio G, Mozzillo E, Raia V. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? Diabetes Care 2005; 28: 2333.
11. 1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care 2000; 23: 126.
12. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2000; 21: 691-696.
13. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Wei R, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 2002; 246: 1-190.
14. Mastrototaro J. The Minimed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 1999; 12: 751-758.
15. WHO. Consultation on Definition Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of WHO Consultation. Geneva: World Health Organization, 1999; 1-49.
16. Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child 1991; 66: 612-616.
17. Cucchiara S, Raia V, Minella R, Frezza T, De Vizia B, De Ritis G. Ultrasound measurement of gastric emptying time in patients with cystic fibrosis and effect of ranitidine on delayed gastric emptying. J Pediatr 1996; 128: 485-488.
18. 1c. in pediatric type I diabetic patients. Diabetes Care 2002; 25: 1840-1844.
19. Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the Gluco Watch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care 2004; 27: 722-726.
20. Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003; 26: 1940-1941.
21. Jefferies C, Solomon M, Perlman K, Sweezy N, Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005; 147: 396-398.